Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Antibody reactivity to a synthetic peptide (P62) of the Epstein-Barr nuclear antigen in sera of patients with X-linked lymphoproliferative syndrome.

Thiele G, Bicak M, Grierson H, Lai P, Purtilo D.

J Immunol Methods. 1987 Jun 26;100(1-2):249-59.

PMID:
3036951
2.
3.

The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1).

Rumpold H, Rhodes GH, Bloch PL, Carson DA, Vaughan JH.

J Immunol. 1987 Jan 15;138(2):593-9.

PMID:
2432130
4.

Antibodies to an Epstein-Barr virus nuclear antigen synthetic peptide in infectious mononucleosis. Report of two cases.

Smith RS, Rhodes G, Geltosky JE, Horwitz CA.

Am J Clin Pathol. 1989 Oct;92(4):447-51.

5.

Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera.

Kouri T, Petersen J, Rhodes G, Aho K, Palosuo T, Heliövaara M, Isomäki H, von Essen R, Vaughan JH.

J Rheumatol. 1990 Nov;17(11):1442-9.

PMID:
2177109
7.
8.

Use of enzyme-linked immunosorbent assays with chimeric fusion proteins to titrate antibodies against Epstein-Barr virus nuclear antigen 1.

Inoue N, Kuranari J, Harada S, Nakajima H, Ohbayashi M, Nakamura Y, Miyasaka N, Ezawa K, Ban F, Yanagi K.

J Clin Microbiol. 1992 Jun;30(6):1442-8.

9.

Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.

Dillner J, Sternås L, Kallin B, Alexander H, Ehlin-Henriksson B, Jörnvall H, Klein G, Lerner R.

Proc Natl Acad Sci U S A. 1984 Aug;81(15):4652-6.

10.
11.

Detection of antibodies to Epstein-Barr virus antigens by enzyme-linked immunosorbent assay.

Hopkins RF 3rd, Witmer TJ, Neubauer RH, Rabin H.

J Infect Dis. 1982 Dec;146(6):734-40.

PMID:
6183369
12.
13.
14.

Serum IgA cross-reactivity between glycine-alanine repeat sequence of EBNA-1 and keratin or collagen in nasopharyngeal carcinoma.

Mathew A, Cheng HM, Sam CK, Prasad U.

Clin Immunol Immunopathol. 1994 May;71(2):164-8.

PMID:
7514112
15.
16.

Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein-Barr nuclear antigen-1.

Baboonian C, Halliday D, Venables PJ, Pawlowski T, Millman G, Maini RN.

Rheumatol Int. 1989;9(3-5):161-6.

PMID:
2481875
17.

Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.

Rhodes G, Carson DA, Valbracht J, Houghten R, Vaughan JH.

J Immunol. 1985 Jan;134(1):211-6.

PMID:
2981091
18.

Development of a recombinant enzyme-linked immunosorbent assay for detection of antibodies against Epstein-Barr virus nuclear antigens 2A and 2B.

Geertsen R, Espander-Jansson A, Dobec M, Price P, Wunderli W, Rymo L.

J Clin Microbiol. 1994 Jan;32(1):112-20.

19.

Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1.

Venables PJ, Pawlowski T, Mumford PA, Brown C, Crawford DH, Maini RN.

Ann Rheum Dis. 1988 Apr;47(4):270-9.

20.

Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen.

Dölken G, Weitzmann U, Boldt C, Bitzer M, Brugger W, Löhr GW.

J Immunol Methods. 1984 Mar 16;67(2):225-33.

PMID:
6323578
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk